Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin plus zinc oxide vs zinc oxide for moisture-associated skin damage
IRCT20120731010453N9Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of atorvastatin in Moisture-associated skin damage (MASD) (2 arms), sponsored by Shiraz University of Medical Sciences. Started Nov 2025; status: completed.
02
Drugs
atorvastatin
03
Conditions
Moisture-associated skin damage (MASD)
Beyond the preview
Go deeper on IRCT20120731010453N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120731010453N9.